Ledger.Open graph →
SEC Form D · Amendment · filed September 13, 2023

Endolytix Technology, Inc

Offering
$4.3M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BEVERLY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Westly Nolin · Beverly, MAExec · DirectorRon Zwanziger · Beverly, MADirectorRouxi Hu · Beverly, MAExec · DirectorRouxi Hu · Beverly, MAExec · DirectorRon Zwanziger · Beverly, MADirectorWestly Nolin · Beverly, MAExec · DirectorSamantha Beattie · New York, NYDirectorGaurav Gupta · New York, NYExec · DirectorStephen Squinto · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗